ロード中...
Diagnosis and Screening of Patients with Hereditary Transthyretin Amyloidosis (hATTR): Current Strategies and Guidelines
The outlook for transthyretin amyloidosis (ATTR) is changing with the availability of new and emerging treatments. ATTR now appears to be more common than previously thought and is no longer viewed as an obscure diagnosis with a grim prognosis. Now more than ever, there is growing emphasis on the ne...
保存先:
| 出版年: | Ther Clin Risk Manag |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7434568/ https://ncbi.nlm.nih.gov/pubmed/32884276 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S185677 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|